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Abstract
Background: Little is known about the prevalence of pulmonary tuberculosis (TB) in low income countries. We 
conducted a cross sectional survey for pulmonary TB and TB symptoms in Bissau, Guinea-Bissau, in an urban cohort 
with known HIV prevalence. TB surveillance in the area is routinely based on passive case finding.
Methods: Two cohorts were selected based on a previous HIV survey, but only 52.5% of those enrolled in the adult 
cohort had participated in the HIV survey. One cohort included all adults living in 384 randomly selected houses; in this 
cohort 8% (135/1687) were HIV infected. The other included individuals 50 years or older from all other houses in the 
study area; of these 11% (62/571) were HIV infected. Symptom screening was done through household visits using a 
standardised questionnaire. TB suspects were investigated with sputum smear microscopy and X-ray.
Results: In the adult cohort, we found 4 cases among 2989 individuals screened, giving a total TB prevalence of 134/
100,000 (95% CI 36-342/100,000). In the >50 years cohort, we found 4 cases among 571 individuals screened, giving a 
total prevalence of 701/100,000 (191-1784/100.000). Two of the eight detected TB cases were unknown by the TB 
program. Of the total TB cases five were HIV uninfected while three had unknown HIV status. The prevalence of TB 
symptoms was 2.1% (63/2989) and 10.3% (59/571) in the two cohorts respectively.
Conclusions: In conclusion we found a moderately high prevalence of pulmonary TB and TB symptoms in the general 
population, higher among elderly individuals. By active case finding unknown cases were detected. Better awareness 
of TB and its symptoms needs to be promoted in low income settings.
Background
Tuberculosis (TB) is a global emergency; each year 1.7
million people die of TB[1]. In Sub-Saharan Africa the
situation is particularly critical, often because HIV fuels
the TB epidemic [2,3].
Yet, there are still major gaps in our epidemiological
knowledge [4]. In low resource settings the TB incidence
rates available are often of poor accuracy and the true
spread of the disease is therefore unknown [5]. Good TB
prevalence data are even more scarce though some sur-
veys from around the world are available [6-15]. It is pos-
sible that the true magnitude of the epidemic is
underestimated and many TB cases might never be diag-
nosed [5]. Left untreated, a TB patient can infect between
10 and 15 persons per year [16]. Such unknown cases,
especially the more infectious sputum smear positive
[17], could therefore play an important role in the spread
of the disease and remain a challenge to TB programs.
We here report the findings of a cross sectional TB sur-
vey performed in Bissau, Guinea-Bissau, West Africa.
The study was conducted in a cohort where the HIV
prevalence was recently assessed making a combined
estimate possible. The main objective was to determine
the prevalence of active TB and TB symptoms in the
overall adult population in a sample of 384 houses as well
as in the total population above 50 years of age.* Correspondence: mban@dadlnet.dk
1 Bandim Health Project, INDEPTH Network, Apartado 861, 1004 Bissau Codex, 
Guinea-Bissau
Full list of author information is available at the end of the article
Bjerregaard-Andersen et al. BMC Infectious Diseases 2010, 10:96
http://www.biomedcentral.com/1471-2334/10/96
Page 2 of 6
Methods
Study population
The study was conducted at the Bandim Health Project
(BHP), Bissau, Guinea-Bissau in West Africa, a Demo-
graphic Surveillance Site. The BHP is a Danish-Guinean
research station, with a study area consisting of 6 subur-
ban districts in the capital Bissau and a total study popu-
lation of 92,000. All individuals are registered with ID-
number, age, sex, ethnic group and socio-economic char-
acteristics. The information is updated through regular
censuses.
An extensive TB surveillance system based on passive
case finding has been in place since 1996 [18]. A previous
study showed that TB is highly endemic in Bissau with an
incidence of 471/100,000 for adults [18]. All known TB
cases occurring in the study area are registered in a cen-
tral database at the BHP. The information is obtained at
local health centres and the national TB hospital.
Deceased TB patients and selected suspects have a ver-
bal autopsy performed. This consists of a thorough inter-
view of close relatives regarding symptoms and clinical
signs preceding death. The questionnaire is afterwards
reviewed by two physicians to establish the cause of death
and a third physician in case of discrepancy. Although a
more imprecise measure, the verbal autopsy method has
been validated as a useful tool in developing countries
[19].
Study cohort
Since HIV is one of the most important factors in the
global TB epidemic [2,3], the study cohort was based on
an HIV survey conducted from May 2004 to January 2007
[20]. The individuals eligible for the HIV survey were
divided into two cohorts. One consisted of all adult indi-
viduals above 15 years of age living in 384 randomly
selected houses in three of the suburban districts (Ban-
dim I, Bandim II and Belem), accounting for ~10% of all
houses in that area. This cohort was chosen to provide a
community sample of the distribution of HIV-1 and HIV-
2 and is denoted the "adult cohort". The other cohort
included individuals 50 years or older from the rest of the
houses in the three suburban districts, i.e. houses not
among the 384 random houses. This cohort was selected
in order to examine whether elderly people differ in terms
of HIV-1 and HIV-2 distribution and is denoted ">50
years cohort".
The current TB survey used the same inclusion criteria
and was conducted from February 2006 to July 2007.
However, a re-census was done in the houses in the adult
cohort to account for a high mobility in the study area.
This can partly be explained by migration between urban
and rural areas [21].
Due to the high mobility, an HIV status was not avail-
able for all individuals in the adult cohort. The census
prior to the TB survey identified 3714 eligible individuals,
while the census prior to the HIV survey had identified a
total of 3232 eligible individuals in the adult cohort. The
overlap between eligible individuals was 71.9% (2669/
3714), i.e. 2669 eligible individuals from the HIV survey
were identified again among the 3714 eligible for the TB
survey. Of the overlapping 2669 eligible individuals, the
HIV survey had obtained an HIV status for 1950 persons.
An HIV status was therefore available for 52.5% (1950/
3714) of the eligible individuals in the adult cohort in the
current TB survey.
In the >50 years cohort individuals were only included
if they had been included in the HIV survey. Thus, an
HIV status was available for all individuals in this cohort.
Procedures
The study was based on TB detection by active case find-
ing using house to house visits. Individuals not located at
first house visit were attempted located on at least once
subsequent visit. The primary screening took place where
people lived. Two teams consisting of trained field assis-
tants visited the eligible individuals and screened them
for TB symptoms using standardized questionnaires [4].
Individuals were asked for presence of the following TB
symptoms: cough, expectorate, haemoptysis (coughing
blood), breathlessness, chest pain, fever, nightly sweats,
fatigue, weight loss and loss of appetite. Individuals with
cough or two other TB symptoms were referred to a phy-
sician for further clinical investigation. Sputum smear
and X-ray was ordered if the physician also considered
the referred individual a TB suspect. If an individual was
HIV infected, one TB symptom alone would indicate
referral. Individuals reporting haemoptysis were always
referred. Referred individuals who did not appear at the
health centres were re-invited at least once.
TB case definitions
The diagnosis of TB was made according to WHO guide-
lines [17]. TB culture was not available as diagnostic facil-
ities were destroyed during a civil war [22]. Suspects with
two or more sputum smears positive at direct microscopy
for acid fast bacilli were regarded as smear positive TB
cases. Smear negative individuals with clinical symptoms
and X-ray signs of pulmonary TB were treated with anti-
biotics for two weeks and then re-evaluated. If the symp-
toms persisted and the X-ray was still compatible with TB
the person was regarded as a smear negative TB case.
Individuals in anti-TB therapy at time of screening and
registered through the TB surveillance were defined as
"known cases", whereas TB cases not registered were
classified as "unknown cases". TB cases were treated
according to national guidelines. An HIV treatment pro-
gram is currently being implemented in Bissau, but was
not available during the study. Patient delay for con-
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firmed TB patients was defined as the period between
onset of any TB symptom and treatment initiation [23].
Ethics and consent
Ethical permission was obtained from "Unidade de Coor-
dinação de Estudos e Pesquisas em materio de Saúde", the
National Ethical Committee of The Ministry of Health in
Guinea-Bissau. Written informed consent, either by sig-
nature or fingerprint, was obtained for all screened indi-
viduals.
Statistical analysis
Data was entered using dBASE V software. As age in the
two cohorts was not normally distributed, median values
were used and age comparisons between groups were
performed using the wilcoxon rank-sum test. For dichot-
omous variables the chi-square test was used. A two-
sided P < 0.05 was considered significant. Prevalence of
TB symptoms according to HIV status was adjusted to
the age distribution in the total study cohort. When cal-
culating an overall estimate of the prevalence of TB
symptoms the number of individuals referred to clinical
consultation was used. All statistical analysis in this study
was done using STATA 9.0 software (Stata Corporation,
College Station, Texas, USA).
Sample size
The previous study found a smear positive TB incidence
of 177/100.000 per year [18]. Assuming the TB program
only detects about half of the TB cases, we expected a
true smear positive TB incidence of 354/100.000. Using a
global estimate of duration of disease of approximately
one year [5], we would also expect a smear positive TB
prevalence of 354/100.000 since Prevalence = Incidence *
Duration of disease [5]. Assuming approx. 3000 individu-
als could be screened in the adult cohort during one year,
we would expect a 95% confidence interval of 183-665/
100.000, which was considered acceptable for the study.
Results
The study cohort consisted of 3714 eligible individuals in
the adult cohort and 718 in the >50 years cohort. It was
possible to locate 2989 (80.5%) and 571 (79.5%) individu-
als from the two cohorts, respectively. Individuals not
located were either at work, at the market, travelling or
for some other reason absent. A total of 26 individuals
who declined to participate were included among those
not screened. Among screened individuals, the median
age in the adult cohort was 28.1, 44.0% (1315/2989) were
male. In the >50 years cohort the median age was 62.3,
42.2% (241/571) were male. Baseline characteristics are
shown in Additional file 1, Table 1. In the adult cohort,
screened individuals were younger than those not
screened and were more often women. In the >50 years
cohort there were no significant differences between the
groups.
The results of the screening and subsequent TB exami-
nations are displayed in Figure 1. Symptom screening
identified 61 suspects of TB in the adult cohort and 55 in
the >50 years cohort. Median age among suspects in the
adult cohort was 33.8 and 23.0% (14/61) were male.
Among suspects from the >50 years cohort the median
age was 61.9 and 34.6% (19/55) were male. Total HIV
prevalence was 38.5% (15/39) and 20.0% (9/45) in the two
groups, respectively.
Of the TB suspects referred, 52 and 48 from the respec-
tive cohorts appeared for investigation at the local health
centres. Previously unknown TB was diagnosed in two
females from the adult cohort aged 24 and 50 year. One
was smear positive, the other smear negative. Both were
HIV uninfected and reported no contact with other TB
patients. One of the two patients left the study area prior
to TB treatment initiation. In total 14 TB suspects had X-
ray findings which could be suggestive of pulmonary TB
but turned out to be sputum smear negative. Smear nega-
tive TB was ruled out by secondary X-rays or effect of
antibiotic treatment. Differences between X-ray findings
in two cohorts were in general not observed although two
patients from the >50 years cohort had cicatricial X-ray
findings suggestive of former TB. Through the TB regis-
tration system 6 known cases were identified among par-
ticipants from the two cohorts, 2 from the adult cohort
and 4 from the >50 years cohort. Two were males. Three
were HIV negative, for the three remaining HIV status
was not available. Thus, based on 4/2989 TB cases in the
adult cohort and 4/571 in the >50 years cohort we calcu-
lated a total prevalence of 134/100,000 and 701/100,000,
respectively. TB prevalence estimates are displayed in
Additional file 1, Table 1.
One TB suspect in the >50 years cohort died before a
diagnosis was established. A verbal autopsy determined
that TB was the most likely cause of death, but this per-
son has not been included as a TB case as a verbal
autopsy diagnosis has a greater degree of uncertainty. If
the person had been included, the TB prevalence in the
>50 years cohort would have been 876/100,000 (285-
2032/100,000).
Among the 6 known TB cases found in the two cohorts,
clinical data was available for 3 patients in whom treat-
ment delay was 1, 2 and 4 months. The mean delay (± SD)
was 70 days (± 46). For the two unknown TB cases found
the delay was two weeks and 6 months, respectively.
Apart from self-reported weight loss, TB symptoms in
general were not common in the two cohorts. The overall
prevalence of TB symptoms in the adult cohort was 2.1%
(63/2989) and 10.3% (59/571) in the >50 years cohort,
both estimates including individuals with known active
TB. Additional file 2, Table 2 shows age-adjusted preva-
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lence estimates of TB symptoms in the adult cohort, irre-
spective of duration, and stratified by HIV status.
Discussion
Our study provides population-based data on the preva-
lence of active TB and TB symptoms in a low resource
setting with a well described HIV burden. The main find-
ing was a moderate burden of unknown TB and TB
symptoms in an area with ongoing TB surveillance based
on passive case finding. The number of unknown smear
positive TB was 1 out of a total of 5 smear positive cases.
The total TB prevalence in the community was in the
order of 134/100,000, but much higher among elderly
individuals.
Only few other TB prevalence studies have been con-
ducted in Sub-Saharan Africa and only one with a com-
bined HIV estimate. A survey from Ethiopia identified a
smear positive TB prevalence of 78/100,000 by using
symptom screening [11]. The burden of previously
unknown smear positive TB was higher in the Ethiopian
study, since there was one unknown smear positive case
for every two cases known by the TB program. By using
fluorescence microscopy as screening method, a study
from Eritrea identified a total smear positive prevalence
of 90/100,000 in the adult population [10]. A recent sur-
vey from South Africa encountered a much higher bur-
den of previously undiagnosed TB, i.e. 1.575/100,000 out
of a total prevalence of 2.517/100,000 [14]. The high TB
prevalence in South Africa was mainly attributed to an
HIV-1 prevalence of around 23%.
The previous survey in our study area found a smear
positive TB incidence of 177/100,000 [18]. Defining dura-
tion of disease as the 8 months of TB treatment, one
would expect a prevalence of known smear positive TB of
177/100,000 * 8/12 = 118/100,000, which is in the same
order as the prevalence encountered in the present study.
Our data also suggests a long delay between onset of
symptoms and treatment initiation (approx. 2 months).
The reason for this remains unknown, but a lack of TB
awareness and reliance on private healers could play a
role [23,24]. Also, repeated visits to health clinics without
correct diagnosis could be an explanatory factor [23].
Finally, it is worth noting that the two unknown cases
were women. Female sex has previously been associated
with undiagnosed TB [11] and a longer patient delay [23].
Figure 1 Study flowchart. Results of inclusion, screening and TB investigation.
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N = 2 
Lost follow 
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Suspects investigated, N = 52 Suspects investigated, N = 48 
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N = 3714 (100%) 
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N = 718 (100 %) 
Screened  
N = 2989 (80.5 %) 
Screened 
N = 571 (79.5 %) 
No TB 
N = 2926 
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TB symptoms were only moderately prevalent in the
adult cohort, but the prevalence was higher among
elderly. The Ethiopian study found 2.6% of the adult pop-
ulation to be symptomatic [11], which is close to our find-
ings. In the adult cohort most TB symptoms were more
prevalent among HIV-2 infected, but this also reflects a
higher morbidity among elderly, who are predominately
HIV-2 infected. Thus, no correlation between HIV status
and TB symptoms was established after age-adjustment.
The fact that the prevalence symptoms among HIV-1 and
HIV uninfected was in the same order most likely reflects
that the HIV-1 epidemic in Bissau is still relatively young
[20] and most HIV-1 infected remain asymptomatic.
Since TB surveys are costly [25], the most effective way
of targeting hidden TB and reducing patient delay is
probably increased education of health care providers
and TB information campaigns. The focus should be
symptoms, modes of transmission and that it is most
likely a curable condition.
Our TB survey has several limitations. Since the TB
survey was performed in a cohort with a well described
HIV burden the sample size is relatively small and esti-
mates are therefore subject to a considerable uncertainty
error. Also, some individuals could have been HIV
infected between the HIV and the TB survey, thereby
biasing some of the results. Another limitation is that the
overlap between the HIV and TB survey was low, only
52.5% of screened individuals in the adult cohort had a
known HIV status. This reflects that the study population
is highly mobile. We could have chosen to include only
individuals with known HIV status, but preferred to
include all adults in order to obtain the most recent and
precise community sample and to avoid introducing the
bias of enrolling only the non-mobile individuals known
from the HIV survey for TB screening.
As Bissau is a resource limited setting we chose a symp-
tom screening model. Although logistically feasible this
increases the risk of overlooking TB patients that were
asymptomatic or under-reporting symptoms [14]. The
examination of symptomatic patients could have been
further improved by using sputum culture, as this offers
the highest sensitivity in both HIV infected and unin-
fected patients [26]. Unfortunately this was not possible
at the time of study as diagnostic facilities were destroyed
during a civil war [22]. TB culture is currently being
implemented in Bissau.
Ideally, in a TB prevalence survey sputum smear and
culture should be performed on all screened individuals.
This is especially true in areas where TB-HIV co-infec-
tion is the major factor, since culture here offers a mark-
edly higher sensitivity [26]. However, any TB survey must
take logistical and financial constraints into consideration
but also outweigh the costs and benefits of improved
screening vs. expanding the sample size [4]. Since most
individuals screened reported no symptoms, a future sur-
vey in our study area could include an interview with the
heads of the families in each household followed by
symptom screening and examination only of those
reported symptomatic. Although a number of TB cases
would probably be missed and no HIV status would be
available, a much larger area could be covered thereby
increasing the sample size and potentially diagnosing
many unknown TB cases.
Conclusions
We found a moderately high burden of pulmonary TB
and TB symptoms in this urban setting, especially among
elderly. Unknown cases were detected and we further
noted a long patient delay prior to treatment initiation.
The study underscores the need to conduct TB awareness
campaigns among both health personnel and the general
population in high endemic settings.
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